Latest Safety News

Alterity Therapeutics has reported encouraging topline results from its open-label Phase 2 trial of ATH434 in advanced Multiple System Atrophy, showing slowed disease progression and biomarker stabilization.

Noxopharm Limited has successfully completed the first low-dose cohort in its HERACLES clinical trial for SOF-SKN™, clearing the way for higher dose testing in autoimmune disease treatment.

Grange Resources reported a robust quarter with increased iron ore production and pellet sales at Savage River, maintaining excellent safety standards and managing costs below budget despite accelerated waste stripping. Progress on financing the North Pit Underground project and strategic moves on the Southdown Magnetite Project highlight growth ambitions.

Central Petroleum Limited reports a robust 22% increase in full-year revenue for FY25, driven by new gas sale contracts and strong operational cash flows. Production at key fields remains steady despite temporary constraints.

Greenvale Energy has initiated its first-ever drilling program at the Oasis Uranium Project in Queensland, aiming to validate and extend known uranium mineralisation with advanced techniques.

Toubani Resources has made significant strides in developing its Kobada Gold Project in Mali, securing a $29 million strategic placement and launching extensive drilling programs aimed at expanding its mineral resource base ahead of a final investment decision.

Noble Helium has upgraded its North Rukwa helium resource estimate by nearly 30%, driven by fresh data and a refined charge model, setting the stage for a targeted drilling campaign.

Torque Metals has initiated diamond drilling at its Paris Gold Project to extend promising high-grade gold mineralisation, leveraging government co-funding and advanced geophysical targeting.

Stanmore Resources has reported a robust recovery in its June quarter operations with increased coal production, zero serious safety incidents, and positive cash flow, despite challenging weather conditions. The company maintains its full-year production guidance, signaling resilience amid market uncertainties.

Develop Global Limited has marked a pivotal quarter with initial concentrate shipments from its Woodlawn Copper-Zinc Mine, the commencement of earthworks at Sulphur Springs, and a substantial A$180 million capital raise to fuel an aggressive growth strategy.

Radiopharm Theranostics has received FDA clearance to begin a Phase I clinical trial for RV-01, a novel radiopharmaceutical targeting the 4Ig isoform of B7-H3 in solid tumors, marking a significant step forward in cancer treatment innovation.

Carawine Resources advances exploration planning at Paterson and other projects while facing a pivotal court decision on shareholder compulsory acquisition and securing a $1.7 million loan to sustain operations.